Back to BlackRock, Inc. BlackRock, Inc.

VNDAVNDA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in VANDA PHARMACEUTICALS INC

BlackRock, Inc. holds 7.7M shares of VNDA (VANDA PHARMACEUTICALS INC), worth $46.8M as of 2026-Q2. The position was increased (+5.2% shares). VNDA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$46.8M

Current Shares

7.7M

Total Value Change

+$3.2M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.7M
+5.2%
$46.8M0.0%$6.12
31
2026-Q1
Decreased
7.3M
-6.4%
$50.3M0.0%$7.84
0
2025-Q4
Decreased
7.8M
-12.8%
$68.6M0.0%$7.03
0
2025-Q3
Decreased
8.9M
-5.5%
$44.5M0.0%$4.91
0
2025-Q2
Increased
9.4M
+3.4%
$44.5M0.0%$4.78
30
2025-Q1
Increased
9.1M
+0.3%
$41.9M0.0%$4.69
29
2024-Q4
New
9.1M
-
$43.6M0.0%$4.78
40

Other major holders of VNDA: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used